Level 3 Communications, Inc. (NYSE:LVLT) shares decreased -4.21% in last trading session and ended the day at $50.69. LVLT Gross Margin is 47.40% and its has a return on assets of 0.80%. Level 3 Communications, Inc. (NYSE:LVLT) quarterly performance is 14.35%.
Level 3 Communications, Inc. (NYSE:LVLT) announced the Defense Information Systems Agency (DISA) has awarded the company a multiple-year competitive contract known as Global Network Services (GNS). The contract allows Level 3 to bid on and provide communications services to support DISA’s goal of providing a single global network including both wired and wireless technologies by 2020.
Geron Corporation (NASDAQ:GERN) caters to the Healthcare space. It has a net profit margin of -1.10% and weekly performance is -22.38%. On the last day of trading company shares ended up at $3.85. Geron Corporation (NASDAQ:GERN) distance from 50-day simple moving average (SMA50) is -11.45%.
Geron Corporation (NASDAQ:GERN) said that, MALACAÑANG has appointed Deputy Executive Secretary Ronaldo A. Geron as new head of the Bureau of Immigration replacing Siegfred B. Mison. In a text message, Department of Justice (DOJ) Undersecretary and Spokesman Emmanuel Caparas said Geron took his oath last Jan. 6, 2016.
On 07 January, Total System Services, Inc. (NYSE:TSS) shares decreased -3.03% and was closed at $46.45. TSS EPS growth in last 5 year was 5.40%. Total System Services, Inc. (NYSE:TSS) year to date (YTD) performance is -6.73%.
Total System Services, Inc. (NYSE:TSS) said that, it will issue its fourth-quarter earnings report on January 26, 2016, at approximately 4:15 p.m. ET. A conference call to discuss these results, business trends and future projections will be held on January 26, 2016 at 5:00 p.m. ET.
Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares decreased -7.97% in last trading session and ended the day at $13.17. CLDX has a return on assets of -36.30%. Celldex Therapeutics, Inc. (NASDAQ:CLDX) quarterly performance is 10.12%.
Zacks Investment Research downgraded shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX) from a buy rating to a hold rating in a research report published on Monday morning, Market Beat reports.
Hooper Holmes Inc. (NYSEMKT:HH) caters to the Healthcare space. It has a net profit margin of -31.40% and weekly performance is -8.56%. On the last day of trading company shares ended up at $0.06. Hooper Holmes Inc. (NYSEMKT:HH) distance from 50-day simple moving average (SMA50) is -47.50%.
Hooper Holmes Inc. (NYSEMKT:HH) announced that on December 31, 2015, the Company elected to extend the period during which the subscription rights may be exercised so that they will expire if they are not exercised by 4:00 p.m., central time, on January 25, 2016 due to delays in getting the prospectus mailed during the Holiday Season. All references in prior press releases and filings to a different time or date for the subscription period to end are amended to reflect this new date and time.
Leave a Reply